Product NDC: | 59762-0540 |
Proprietary Name: | Glipizide |
Non Proprietary Name: | glipizide |
Active Ingredient(s): | 2.5 mg/1 & nbsp; glipizide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59762-0540 |
Labeler Name: | Greenstone LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020329 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20130529 |
Package NDC: | 59762-0540-1 |
Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0540-1) |
NDC Code | 59762-0540-1 |
Proprietary Name | Glipizide |
Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0540-1) |
Product NDC | 59762-0540 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | glipizide |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130529 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Greenstone LLC |
Substance Name | GLIPIZIDE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |